Fig. 5.
TLR2 expression on CD19+/CD5+ cells of CLL patients depending on the presence cytogenetic aberrations (del(11q22) and del(17p13)). a Percentage of TLR2-positive CD19+/CD5+ cells; b mean fluorescence intensity (MFI) of TLR2
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.